CStone Pharmaceuticals (FRA:PH4) Short Interest


FRA:PH4 CStone Pharmaceuticals FRA:PH4
56 GF Score
Price €0.52
GF Value €0.13
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is CStone Pharmaceuticals Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:PH4 vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, CStone Pharmaceuticals's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CStone Pharmaceuticals Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CStone Pharmaceuticals's Short Interest distribution charts can be found below:

* The bar in red indicates where CStone Pharmaceuticals's Short Interest falls into.


FRA:PH4
56GF Score
CStone Pharmaceuticals FRA:PH4
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is CStone Pharmaceuticals (FRA:PH4) Overvalued in 2026?

Based on GuruFocus' analysis, CStone Pharmaceuticals stock appears to be overvalued. The current stock price of €0.52 is trading 301.4% above its estimated GF Value™ of €0.13. GuruFocus considers CStone Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for FRA:PH4:

  • Short Interest:
  • GF Value™: €0.13 vs. price of €0.52 (301.4% above fair value)
  • GF Score™: 56/100 with 7 warning signs

No single metric tells the full story. See the FRA:PH4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CStone Pharmaceuticals Business Description

Address 218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Suzhou, CHN, 215123
CStone Pharmaceuticals is engaged in developing and commercializing immuno-oncology and molecularly targeted drugs to address unmet medical needs in cancer treatment. The Group has been operating in one reportable segment, being the research and development of high-complex biopharmaceutical products, the sale of pharmaceutical products, and provide license of its IP or commercialisation licenses to customers.
56GF Score

Get the complete analysis for FRA:PH4

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.52
Price
€0.13
GF Value